TraceLink Announces Systems to Accelerate Digital Supply Chain Transformation

Systems are meant to provide critical transparency to the Life Sciences supply chain, mobilizing companies to rapidly react to unforeseen disruptions and ensure medicine supply

TraceLink has prioritized its product roadmap and investment strategy to focus on delivering systems.
TraceLink has prioritized its product roadmap and investment strategy to focus on delivering systems.

TraceLink, a digital platform company for the life sciences industry, announces a package of agile systems designed to digitalize the pharmaceutical supply chain. In response to COVID-19, TraceLink has prioritized its product roadmap and investment strategy to focus on delivering systems that are meant to help companies meet unforeseen supply chain challenges and ensure the safe delivery of critical medicines and supplies to their patients. 

TraceLink also announces the commitment of a $1 million donation to COVID-19 charitable relief efforts. Building on TraceLink’s commitment to secure the pharmaceutical and healthcare supply chains, this donation is supposed to address the needs of COVID-19 relief. TraceLink is currently accepting grant proposals from charities and organizations around the world that are leading COVID-19 research and relief efforts.

“The world is facing a global health and supply chain crisis where the ability to collaborate and coordinate across the network has become essential to society. In response to this crisis, we prioritized our product focus to deliver solutions that bring speed and agility to our customers’ supply chains, while also giving back to the industry with a charitable grant to support COVID-19 relief efforts,” says Shabbir Dahod, president and CEO, TraceLink. “We are dedicated to helping our customers meet their compliance obligations and solve critical supply chain challenges—and will continue to make strategic business investments to further support the industry in today’s new normal.” 

Available on TraceLink’s Opus platform, the systems tap into TraceLink’s end-to-end network connectivity, data sharing, and multi-party process orchestration, which should give companies the visibility and responsiveness needed for their supply chains to thrive in today’s challenging environment. 

These systems on the TraceLink Opus Platform are made with the following features:

  • Agile Issue Management: a centralized network-based system meant to identify, track, and resolve supply partner issues in real-time. Agile Issue Management should connect internal teams with external suppliers and downstream customers to manage unforeseen supply chain disruptions and resolve them faster.
  • Drug Shortage Intelligence: when supply and demand experience massive fluctuation, drug shortages are inevitable. By leveraging the power of TraceLink’s network data and advanced analytics, TraceLink’s Drug Shortage Intelligence system is meant to provide network wide insights into supply and patient demand and allow customers to accurately predict and prevent drug shortages, to ensure critical medicines are available to every patient.  
  • Smart Distribution Tracking: By integrating Internet of Things (IoT) with product serialization, this system is made to provide full track and trace visibility for the secure delivery of vaccines, test kits and high-value products.

The 280,000 members on the TraceLink network have commissioned over 11 billion serial numbers to date, tracking serialized medicines as they move through the supply chain. With the Opus platform, TraceLink customers should be able to unlock value from their digitalized supply chains and provide the means to orchestrate patient outcomes.  

Companies in this article
More in COVID-19